Nutanix (NTNX) Likely to Beat on ACV but Miss on EPS - Morgan Stanley

August 27, 2021 6:59 AM EDT Send to a Friend
Morgan Stanley analyst Katy Huberty reiterated an Equalweight rating and $41.00 price target on Nutanix (NASDAQ: NTNX) expecting ACV to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login